Elevance Health Inc (ELV) reported Q3 2025 earnings of $6.03 per share, surpassing analyst expectations of $4.98. Revenue for the quarter totaled $50.1 billion, also exceeding the forecast of $49.9 billion. This performance reflects robust operational health for the company.
The earnings conference call will be held at BMO, where management will discuss these results and provide additional insights on business performance. Elevance Health operates as a health insurer in the U.S. and employs over 103,000 individuals. The firm segments its operations into Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
With a market capitalization of $69.9 billion and a trailing P/E ratio of 12.63, Elevance Health continues to demonstrate strong financial metrics. Upcoming earnings are scheduled for July 14, 2026, with estimates of $9.18 EPS and $53.1 billion in revenue.